Manage and streamline operations across multiple locations, sales channels, and employees to has improve efficiency and your bottom line.

OUR WORKING PROCESS

Building Trust in Pharmaceuticals Since 1985

Zyphar’s is an Indian pharmaceutical group with a diversified presence across specialized segments, including Oncology APIs, General Formulations, Retail Pharmacy, and Multi-Specialty Pharmaceutical Distribution. Founded in 1985, the group has built a strong national and international presence, supported by a network of offices across India and a growing team of professionals.

Today, Zyphar’s Biopharmaceuticals operates a cGMP-compliant manufacturing facility at Ranjangaon, Maharashtra, one of India’s prominent industrial hubs. The facility is strategically located approximately 60 km from Pune and 240 km from Mumbai, with Ranjangaon being home to several leading global and Indian industrial organizations.

In a relatively short span of time, Zyphar’s has established a presence across nearly 50 countries, earning the trust of customers and business partners through an unwavering commitment to quality, reliability, and service.

 

Zyphar’s — Driven by Concern. Committed to Care. Focused on Cure.

Take Our Services

Our Commitment

Over the years, our commitment to CCC — Concern, Care & Cure has remained at the heart of everything we do. As our pharmaceutical operations expanded, the increasing uncertainty around the availability, consistency, and quality of APIs created a critical need for greater control over our supply chain. To address this strategic requirement and ensure uninterrupted delivery to our customers, Zyphar’s Biopharmaceuticals was established in 2022 with a focused objective of developing high-quality API manufacturing capabilities.

Our Integrated Capabilities

Our integrated capabilities across pharmaceutical manufacturing, marketing, distribution, and regulatory expertise provide Zyphar’s with a distinctive advantage in an increasingly competitive global pharmaceutical landscape. We leverage our experience in international marketing, scientific and regulatory documentation, product development, and regulatory submissions to build long-term partnerships and accelerate access to quality pharmaceutical products across markets.

Quality at Our Core

Quality is not merely a standard at Zyphar’s — it is embedded in our culture. Our philosophy of Concern, Care & Cure guides our approach to every product, process, customer, and partnership.

Commitment to Excellence

Looking ahead, our growth strategy is driven by product and process innovation, faster turnaround times, operational efficiency, stringent quality standards, and a customer-centric approach. We remain committed to creating sustainable value for our customers, employees, and business partners while strengthening Zyphar’s position as a trusted and globally integrated pharmaceutical organization.

Guided by Purpose. Driven by Excellence.

At Zyphar’s, our vision and mission are driven by Concern, Care & Cure, guiding us to deliver quality, foster innovation, and build lasting trust in healthcare.

VISION

To build a globally respected pharmaceutical enterprise that transforms healthcare through quality, innovation and enduring trust.

MISSION

To develop, manufacture and deliver reliable pharmaceutical solutions that create lasting value for patients, partners and communities, driven by excellence, innovation and our commitment to Concern, Care & Cure.

Our Group Companies

Together, they form a strong and integrated ecosystem driven by shared values, industry expertise, quality, and a commitment to delivering trusted healthcare solutions.